SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 323 filers reported holding SAREPTA THERAPEUTICS INC in Q2 2018. The put-call ratio across all filers is 0.96 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2019 | $70,972,000 | -24.8% | 550,000 | -56.1% | 3.14% | -30.1% |
Q3 2019 | $94,338,000 | +13.2% | 1,252,500 | +128.4% | 4.48% | +19.3% |
Q2 2019 | $83,345,000 | +14.5% | 548,500 | -10.2% | 3.76% | +32.3% |
Q1 2019 | $72,771,000 | +136.8% | 610,546 | +116.9% | 2.84% | +98.5% |
Q4 2018 | $30,725,000 | -50.9% | 281,546 | -27.4% | 1.43% | -49.7% |
Q3 2018 | $62,601,000 | +69.1% | 387,600 | +38.4% | 2.84% | +59.6% |
Q2 2018 | $37,010,000 | +76.7% | 280,000 | -54.9% | 1.78% | +74.5% |
Q2 2017 | $20,949,000 | +104.7% | 621,458 | +79.7% | 1.02% | +108.4% |
Q1 2017 | $10,236,000 | +6.9% | 345,811 | -0.9% | 0.49% | -3.9% |
Q4 2016 | $9,572,000 | – | 348,954 | – | 0.51% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Perceptive Advisors | 2,878,979 | $69,182,000 | 7.27% |
Eventide Asset Management | 259,100 | $6,226,000 | 0.97% |
GLADE BROOK CAPITAL PARTNERS LLC | 251,000 | $6,032,000 | 0.93% |
IMS Capital Management | 32,215 | $774,000 | 0.91% |
Perceptive Advisors | 350,000 | $8,413,000 | 0.88% |
Benchmark Capital Advisors | 34,900 | $839,000 | 0.58% |
BECK CAPITAL MANAGEMENT, LLC | 24,744 | $636,000 | 0.49% |
SABBY MANAGEMENT, LLC | 352,100 | $8,461,000 | 0.47% |
Hatteras Alternative Mutual Funds, LLC | 39,404 | $947,000 | 0.46% |
Potomac Capital Management, Inc. | 22,100 | $531,000 | 0.45% |